Clemson University Report issue

Academic/Hospital Phase 1 Phase 2

Organization Overview

First Clinical Trial
2001
NCT00032500
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Clemson University

Active Ingredients

Drugs in Phase 2 Trials (1)

echinacea (1 trial)

Drugs in Phase 1 Trials (2)

acetylcysteine (mucomyst) (1 trial)

famotidine (pepcid) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Common Cold (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 3